title: TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies.
abstract: TNFR-associated factors (TRAFs) constitute a family of adapter proteins that associate with particular TNF family receptors. Humans and mice contain six TRAF genes, but little is known about their in vivo expression at the single cell level. The in vivo locations of TRAF1, TRAF2, TRAF5, and TRAF6 were determined in human and mouse tissues by immunohistochemistry. Striking diversity was observed in the patterns of immunostaining obtained for each TRAF family protein, suggesting their expression is independently regulated in a cell type-specific manner. Dynamic regulation of TRAFs was observed in cultured PBLs, where anti-CD3 Abs, mitogenic lectins, and ILs induced marked increases in the steady-state levels of TRAF1, TRAF2, TRAF5, and TRAF6. TRAF1 was also highly inducible by CD40 ligand in cultured germinal center B cells, whereas TRAF2, TRAF3, TRAF5, and TRAF6 were relatively unchanged. Analysis of 83 established human tumor cell lines by semiquantitative immunoblotting methods revealed tendencies of certain cancer types to express particular TRAFs. For example, expression of TRAF1 was highly restricted, with B cell lymphomas consistently expressing this TRAF family member. Consistent with results from tumor cell lines, immunohistochemical analysis of 232 non-Hodgkin lymphomas revealed TRAF1 overexpression in 112 (48%) cases. TRAF1 protein levels were also elevated in circulating B cell chronic lymphocytic leukemia specimens (n = 49) compared with normal peripheral blood B cells (p = 0.01), as determined by immunoblotting. These findings contribute to an improved understanding of the cell-specific roles of TRAFs in normal tissues and provide evidence of altered TRAF1 expression in lymphoid malignancies.
authors.affiliation: The Burnham Institute, Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Zapata
authors.forename: M
authors.initials: M
authors.lastname: Krajewska
authors.forename: S
authors.initials: S
authors.lastname: Krajewski
authors.forename: S
authors.initials: S
authors.lastname: Kitada
authors.forename: K
authors.initials: K
authors.lastname: Welsh
authors.forename: A
authors.initials: A
authors.lastname: Monks
authors.forename: N
authors.initials: N
authors.lastname: McCloskey
authors.forename: J
authors.initials: J
authors.lastname: Gordon
authors.forename: T J
authors.initials: TJ
authors.lastname: Kipps
authors.forename: R D
authors.initials: RD
authors.lastname: Gascoyne
authors.forename: A
authors.initials: A
authors.lastname: Shabaik
authors.forename: J C
authors.initials: JC
authors.lastname: Reed
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology / Q000378:metabolism; D018858:Germinal Center / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism; D008223:Lymphoma / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008969:Molecular Sequence Data; D009928:Organ Specificity / Q000276:immunology; D014176:Protein Biosynthesis; D011506:Proteins / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000096:biosynthesis*; D017386:Sequence Homology, Amino Acid; D013194:Staining and Labeling; D047990:TNF Receptor-Associated Factor 1; D014407:Tumor Cells, Cultured
chemical_list: D011506:Proteins; D018124:Receptors, Tumor Necrosis Factor; D047990:TNF Receptor-Associated Factor 1